tiprankstipranks
Rapid Dose Therapeutics Corp (TSE:DOSE)
:DOSE
Canadian Market

Rapid Dose Therapeutics Corp (DOSE) Price & Analysis

Compare
6 Followers

DOSE Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

0.23%99.77%
Mutual Funds
― Other Institutional Investors
99.77% Public Companies and
Individual Investors

DOSE FAQ

What was Rapid Dose Therapeutics Corp’s price range in the past 12 months?
Rapid Dose Therapeutics Corp lowest stock price was C$0.13 and its highest was C$0.33 in the past 12 months.
    What is Rapid Dose Therapeutics Corp’s market cap?
    Rapid Dose Therapeutics Corp’s market cap is C$25.69M.
      When is Rapid Dose Therapeutics Corp’s upcoming earnings report date?
      Rapid Dose Therapeutics Corp’s upcoming earnings report date is Jul 25, 2025 which is in 114 days.
        How were Rapid Dose Therapeutics Corp’s earnings last quarter?
        Rapid Dose Therapeutics Corp released its earnings results on Jan 29, 2025. The company reported -C$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.011.
          Is Rapid Dose Therapeutics Corp overvalued?
          According to Wall Street analysts Rapid Dose Therapeutics Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Rapid Dose Therapeutics Corp pay dividends?
            Rapid Dose Therapeutics Corp does not currently pay dividends.
            What is Rapid Dose Therapeutics Corp’s EPS estimate?
            Rapid Dose Therapeutics Corp’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Rapid Dose Therapeutics Corp have?
            Rapid Dose Therapeutics Corp has 128,442,080 shares outstanding.
              What happened to Rapid Dose Therapeutics Corp’s price movement after its last earnings report?
              Rapid Dose Therapeutics Corp reported an EPS of -C$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.091%.
                Which hedge fund is a major shareholder of Rapid Dose Therapeutics Corp?
                Currently, no hedge funds are holding shares in TSE:DOSE
                ---

                Company Description

                Rapid Dose Therapeutics Corp

                Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes and quality of lives in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system. The company also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. It has a research partnership program with McMaster University for developing biopolymer compositions that can offer enhanced drug delivery performance when formulated in oral dissolvable thin films, as well as for developing orally delivered vaccine candidate for COVID-19. Rapid Dose Therapeutics Corp. is based in Burlington, Canada.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Canada Carbon
                THC Biomed INTL
                Neo Performance Materials Inc
                HLS Therapeutics Inc
                Cardiol Therapeutics
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis